The proposal is to reclassify vaginal tablets that include estradiol such as Gina 10, so that they can be purchased over the counter at a pharmacy, without a prescription from a doctor. This would be the first form of HRT to be reclassified in this way.
Reacting to the news, Dr Edward Morris, President of the Royal College of Obstetricians and Gynaecologists, said:
“Vaginal HRT can help with menopausal symptoms in and around the vagina, such as vaginal dryness and discomfort with intercourse. While we support increased access to products like Gina 10, every woman will experience the menopause differently and there is no one size fits all. It is vital that treatment is tailored to her needs and symptoms.
“It is important that women feel that they can speak to a doctor about their symptoms, and discuss all the different treatments available for the menopause, including the different types of treatment which may include HRT. We will be responding to the consultation.”
Haitham Hamoda, Chairman of the British Menopause Society said:
“Our view is that improving access to HRT is a good thing, but it is really important that women can access all the help and advice they need. It’s great that there is so much conversation about menopause now and people are far more open about it. But we don’t want this to come down to a question of self-diagnosis – it’s really important that those thinking about starting HRT get the right information.”
For media enquiries please contact the RCOG press office on +44 (0)7740 175342 or email email@example.com.
Notes to editor
- The consultation is seeking views from GPs, pharmacists and members of the public. Further details can be found on the Government website